Odyssean »

NVE Corporation shares owned by Odyssean

Quarter-by-quarter ownership of NVE Corporation (NVEC) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in NVE Corporation

Tip: Access up to 7 years of quarterly data

All positions including NVE Corporation held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NVE Corporation by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $248k 2.4k 104.55

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding NVE Corporation

Penserra Capital Management
Defiance ETFs
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Renaissance Technologies
Geode Capital Management
Ranger Investment Management
Dimensional Fund Advisors
Punch & Associates Investment Management
Royce & Associates
Two Sigma Investments
Russell Investments
Silverberg Bernstein Capital Management

View all funds holding NVE Corporation